Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRPS22 Antibody | Login | MRPS22 Antibody | ||||||||||||||||
|
||||||||||||||||||
| AP1M2 Antibody | Login | AP1M2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| UBE2D4 Antibody | Login | UBE2D4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| DROSHA Antibody | Login | DROSHA Antibody | ||||||||||||||||
|
||||||||||||||||||
| PARP4 Antibody | Login | PARP4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CAD Antibody | Login | CAD Antibody | ||||||||||||||||
|
||||||||||||||||||
| EPHA4 Antibody | Login | EPHA4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| RPN2 Antibody | Login | RPN2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| NUP214 Antibody | Login | NUP214 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PPP6R2 Antibody | Login | PPP6R2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ANKRD28 Antibody | Login | ANKRD28 Antibody | ||||||||||||||||
|
||||||||||||||||||
| HLA-DMB Antibody | Login | HLA-DMB Antibody | ||||||||||||||||
|
||||||||||||||||||
| NCOR2 Antibody | Login | NCOR2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CLDN18 Antibody | Login | CLDN18 Antibody | ||||||||||||||||
|
||||||||||||||||||
| AVPR1A Antibody | Login | AVPR1A Antibody | ||||||||||||||||
|
||||||||||||||||||
| CTSC Antibody | Login | CTSC Antibody | ||||||||||||||||
|
||||||||||||||||||
| CR2 Antibody | Login | CR2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CRHR1 Antibody | Login | CRHR1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| EPHA3 Antibody | Login | EPHA3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| FANCE Antibody | Login | FANCE Antibody | ||||||||||||||||
|
||||||||||||||||||
| HLA-E Antibody | Login | HLA-E Antibody | ||||||||||||||||
|
||||||||||||||||||
| HNRNPL Antibody | Login | HNRNPL Antibody | ||||||||||||||||
|
||||||||||||||||||
| HRG Antibody | Login | HRG Antibody | ||||||||||||||||
|
||||||||||||||||||
| PCK2 Antibody | Login | PCK2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SLCO1A2 Antibody | Login | SLCO1A2 Antibody | ||||||||||||||||
|
||||||||||||||||||


